On behalf of the Canadian VIGOUR Centre (CVC) and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018).
The first webinar in this series, featuring the symposium presentation by Dr. Gabriel Steg (Lipid Modifying Treatments post ACS), along with a live interactive case study by Dr. Michael Heffernan, and an ODYSSEY OUTCOMES trial update (including data just presented at the American Heart Association Scientific Sessions) by Dr. Shaun Goodman, is scheduled for Tuesday, December 4th at 7:00 pm EDT.
More information on the webinar and how to RSVP can be found below.
